Breadcrumb

What's New at the RI-MUHC ?

The stomach bug that may raise your risk of Alzheimer’s disease

RI-MUHC scientist leads study linking bacterial infection with moderate but significant increase in the risk of Alzheimer’s disease in older adults

Predicting preeclampsia for safer pregnancies

RI-MUHC scientist Dr. Stella Daskalopoulou aims to reduce pregnancy complications by developing a reliable early screening tool

Focused screening of new residents, key to fight TB in Canada

New study provides unique data on tuberculosis infection rates among foreign-born Canadian residents and citizens

Is your child really allergic to antibiotics?

A recent study used direct oral testing to determine whether reactions to antibiotics are actually allergic

From one pregnancy to the next: watch out for repeated complications

A new study shows that when gestational diabetes or hypertension recur, cardiovascular risks rocket

Leaders in COPD care and research

The CanCOLD study, hosted at the RI-MUHC, is one of the most valuable resources in the world to support research on the causes and burden of chronic obstructive pulmonary disease.

Validating hospital data for research and surveillance

Statistical analysis by an RI-MUHC team confirms the validity of hospital diagnostic codes in identifying SARS-CoV-2 infection

Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects

The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...

Where the biology of aging meets the study of health and chronic disease

The Bone, Muscle and Geroscience Research Group at the RI-MUHC is leading the way in Canadian...

First-of-their-kind wearables capture body sounds to continuously monitor health

Researchers from the Montreal Children’s Hospital participated in a study that tested new devices...

Learn more about the RI-MUHC